IIIa - Awesamo Health

Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial

Patient enrollment, demographics, and clinical characteristics A graphical representation of the study schematic and anticipated ...